MedTrace Logo

The Cleveland Cardiometabolic Cohort

NCT03059121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2026-01-28

No results posted yet for this study

Summary

In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

Conditions

  • HIV
  • Lipodystrophy

Interventions

DIAGNOSTIC_TEST

Dual-energy X-ray absorptiometry

Sponsors & Collaborators

  • University Hospitals Cleveland Medical Center

    lead OTHER

Principal Investigators

  • Grace McComsey, MD · University Hospitals Cleveland Medical Center

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2025-05-19
Completion
2025-05-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03059121 on ClinicalTrials.gov